NantKwest, NantCell and NantOmics to Provide Updated Preclinical and Clinical Data in Four Abstracts at Part of the American Society of Clinical Oncology Annual Meeting

by Jen Hodson | May 31, 2019 | Press Releases

Preclinical and Clinical Data Demonstrate Advanced Deployment of Precision Medicine Tools to Analyze and Potentially More Effectively Intervene with Highly Focused Therapeutic Interventions Culver City, May 31, 2019 – NantKwest (Nasdaq:NK), a leading clinical-stage,...

NantHealth® and NantOmics to Reveal New Research Demonstrating Importance of Examining RNA Expression and Individual Biomarkers in Cancer Testing

by Jen Hodson | Feb 14, 2019 | Press Releases

Findings to be presented at the 2019 American Society of Clinical Oncology’s Genitourinary Cancers Symposium San Francisco and Culver City, CA – February 14, 2019 – Scientific teams from NantHealth (NASDAQ: NH) and NantOmics will present two posters at the American...

NantHealth and NantOmics Present Four Research Papers Demonstrating Advancements in Cancer Diagnostics with NantHealth’s GPS Cancer® and Liquid GPS™

by Jen Hodson | Oct 29, 2018 | Press Releases

NantHealth’s Liquid GPS™ technology shows promise in the monitoring of key biomarkers in metastatic colorectal cancer  MUNICH and CULVER CITY, CA – (October 29, 2018) — Significant developments in cancer research were presented by NantHealth...

Tailored Drug Cocktails Offer Hope to Kids with Aggressive Brain Tumors

by Jen Hodson | Aug 27, 2018 | Press Releases

Clinical Trial Tests Personalized Treatments in Push to Improve Pediatric Cancer Survival UCSF Benioff Children’s Hospitals are harnessing next-generation genomic technology to develop individualized drug cocktails in a new trial for children with a type of malignant...

Using the Technology that Powers GPS Cancer ®, Scientists have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer

by Jen Hodson | Aug 27, 2018 | Press Releases

Peer-reviewed research utilizing NantOmics technology gives scientists fresh insights into driving mechanisms behind a form of rare skin cancer. August 27,2018 – CULVER CITY, Calif  — New, peer-reviewed research utilizing NantOmics technology, which powers...

POC FOR CYTOKINES

by Jen Hodson | Jun 12, 2018 | Press Releases

7:02 pm MST |  Jun 8, 2018  |  BioCentury  |  Product Development POC FOR CYTOKINES Cytokines are emerging as a logical combination partner to boost PD-1 responses by Emily Cukier, Senior Writer Download Article...